Centre de recherche du Centre Hospitalier de l'Universite de Montreal

Montreal, Quebec H2X 0C1

4 studies enrolling now · 6 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Enteric Hyperoxaluria, Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Obesity, Overweight

Studies at this site

• OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
• A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer — Recruiting now
• Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria — Stopped early
• A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed